Consolidated Balance Sheets [Abstract] Total current assets Total assets Total assets Assets Total current liabilities Total current liabilities Total liabilities Total liabilities Total stockholders’ equity Beginning balance Ending balance Total stockholders’ equity Total liabilities and stockholders’ equity Total liabilities and stockholders’ equity Consolidated Statements of Operations [Abstract] Gross profit Gross profit Total operating expenses Total operating expenses Loss from operations Loss from operations (Loss) income from operations Other (expense), income net Loss before (provision for) benefit from income taxes Income (loss) before (provision for) benefit from income taxes Loss before income taxes Net loss Net loss Consolidated Statements of Changes in Stockholders’ Equity [Abstract] Beginning balance (in Shares) Ending balance (in Shares) Common stock, shares outstanding (in Shares) Equity Components [Axis] Consolidated Statements of Cash Flows [Abstract] Net cash (used in) provided by operating activities Net cash used in investing activities Net cash provided by financing activities Net (decrease) increase in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year Total cash, cash equivalents and restricted cash presented in the consolidated statements of cash flows Organization and Nature of Business [Abstract] Basis of Presentation and Summary of Significant Accounting Policies [Abstract] Balance, beginning of year Balance, end of year Allowance for credit losses Balance, beginning of year Total Segments [Axis] Antidilutive Securities [Axis] Revision of Previously Issued Consolidated Financial Statements [Abstract] Revision of Prior Period [Axis] Fair Value Measurements [Abstract] Inventories [Abstract] Inventories, net Inventories Property and Equipment, net [Abstract] Long-Lived Tangible Asset [Axis] Property and equipment, net Property and equipment, net Property and equipment Leases [Abstract] Total remaining lease payments Intangible Assets and Goodwill [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Net book value Intangible asset carrying value Accrued Expenses and Other Current Liabilities [Abstract] Accrued expenses and other current liabilities Accrued expenses and other current liabilities Long-Term Debt [Abstract] Total Long term debt after exit fee Long-term debt Commitments and Contingencies [Abstract] Stockholders’ Equity [Abstract] Stock-Based Compensation [Abstract] Statement of Income Location, Balance [Axis] Outstanding at beginning of period (in Shares) Outstanding at end of period (in Shares) Outstanding at beginning of period (in Dollars per share) Outstanding at end of period (in Dollars per share) Unvested balance at beginning of period (in Shares) Unvested balance at end of period (in Shares) Unvested (in Shares) Unvested balance at beginning of period (in Dollars per share) Unvested balance at end of period (in Dollars per share) Income Taxes [Abstract] Current income taxes Deferred income tax (Provision for) benefit from income taxes (in Dollars) (Provision for) benefit from income taxes Income Tax Jurisdiction [Axis] Cash paid for income taxes, net of refunds received Gross deferred tax assets Net deferred tax assets Gross deferred tax liabilities Net deferred tax liability Effective income tax rate Business and Geographical Reporting Segments [Abstract] Consolidation Items [Axis] Geographical [Axis] Subsequent Events [Abstract] Assets Current assets: Cash and cash equivalents Restricted cash Accounts receivable, net of allowance for credit losses of $551 and $433 at December 31, 2025 and 2024, respectively Accounts receivable Prepaid expenses and other current assets Operating lease right-of-use assets Intangible assets, net Goodwill Other assets Liabilities and Stockholders’ Equity Current liabilities: Current portion of long-term debt Less: current portion of long-term debt Accounts payable Deferred revenues Current portion of operating lease liabilities Current portion of contingent consideration Long-term debt, net Deferred revenues and other liabilities Operating lease liabilities, net of current portion Contingent consideration, net of current portion Commitments and contingencies (Note 11) Stockholders’ equity: Series C convertible preferred stock, $0.10 par value; 10,000,000 shares authorized, no shares issued and outstanding Series C Convertible Preferred Stock, par value (in Dollars per share) Preferred stock, stated value (in Dollars per share) Series C Convertible Preferred Stock, shares authorized (in Shares) Series C Convertible Preferred Stock, shares issued (in Shares) Series C Convertible Preferred Stock, shares outstanding (in Shares) Preferred shares outstanding (in Shares) Common stock, $0.001 par value; 150,000,000 shares authorized; 5,888,199 and 4,171,161 shares issued and outstanding at December 31, 2025 and 2024, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares issued (in Shares) Additional paid-in capital Accumulated deficit Revenues, net Revenues Cost of revenues Operating expenses: Engineering and product development Selling and marketing General and administrative Impairment of goodwill Goodwill impairment Other (expense) income: Interest income Other income Net loss per share of common stock - basic (in Dollars per share) Net loss per share of common stock, basic (in Dollars per share) Net loss per share of common stock - diluted (in Dollars per share) Net loss per share of common stock, diluted (in Dollars per share) Weighted average shares of common stock outstanding - basic (in Shares) Weighted average shares of common stock outstanding - diluted (in Shares) Stock-based compensation expense Sale of common stock, net of offering costs Sale of common stock, net of offering costs (in Shares) Issuance of common stock (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Depreciation and amortization Amortization of operating lease right-of-use assets Amortization of deferred financing costs and debt discount Provision for credit losses Stock-based compensation expense Inventory write-off Inventories wrote off Deferred income taxes Changes in operating assets and liabilities: Accounts payable Accrued expenses and other liabilities Deferred revenues Operating lease liabilities Cash flows from investing activities: Cash flows from financing activities: Sale of common stock, net of offering costs Net proceeds from sale of common stock (in Dollars) Supplemental disclosure of cash flow information: Cash paid during the year for interest Supplemental schedule of non-cash operating, investing and financing activities: Transfer of property and equipment to inventories Accrued equity issuance costs included in accounts payable Write-off of contingent consideration to settlement gains Write-off of intangible assets to settlement gains Accrued exit fee recorded as debt discount Accrued payment of contingent consideration Operating lease right-of-use assets obtained in exchange for operating lease liabilities Settlement gains Settlement gains Settlement gains Interest expense Interest expense Loss on disposal of property and equipment Accounts receivable Inventories Prepaid expenses and other assets Purchase of property and equipment Payment of contingent consideration Common Stock [Member] Additional Paid-In-Capital [Member] Accumulated Deficit [Member] Organization and Nature of Business Basis of Presentation and Summary of Significant Accounting Policies Restricted Cash Restricted cash Allowance for Credit Losses Provision for expected losses Write-offs charged against the allowance Other adjustments Accrued Warranty Costs Activity Additions Balance within deferred revenues and other liabilities Disaggregation of Revenue Future Undiscounted Fixed Treatment Code Payments from International Dermatology Recurring Procedures Expected timing of satisfaction period